A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors

Clinical trial NCT05366478 · RECRUITING

Trial details

NCT number: NCT05366478
Sponsor: Suzhou BlueHorse Therapeutics Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Non Small Cell Lung Cancer Cervical Carcinoma

Start date: 2022-05-30
Primary completion: 2024-05-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.